Asthma Treatment Market Volume Analysis, Segments, Value Share and Key Trends

Posted by Arslan on March 24th, 2020

Long-term asthma control medications are projected to witness a sluggish CAGR of around 2.6% during the forecast period (2020-2027). Despite this, sales performance of these medications would remain significantly high as compared to quick-relief medications, as asthma patients are required to follow a strict medication regime. As a result, quick-relief medications would witness limited adoption at an estimated CAGR of around 1.7% during the forecast period.

Demand prospects for asthma therapeutics are likely to gain strength, owing to increasing awareness among patients regarding this condition. This should have led to linear growth of the Asthma Treatment Market; however, a spurt in the sales of generic drugs, thriving on the back of patent expiration of branded drugs, is projected to limit market potential.

The asthma treatment report considers the following years to present the overall market growth:

  • History Year: 2014 - 2018
  • Base Year: 2018
  • Estimated Year: 2019
  • Forecast Year: 2020 – 2027

Key findings of the asthma treatment market study:

  • Regional breakdown of the asthma treatment market based on predefined taxonomy.
  • Innovative manufacturing processes implemented by asthma treatment vendors in detail.
  • Region-wise and country-wise fragmentation of the asthma treatment market to grasp the revenue, and growth outlook in these areas.
  • Changing preferences among consumers across various regions and countries.
  • Factors (Positive and Negative) impacting the growth of the global asthma treatment market.

On the basis of product, the asthma treatment market study consists of:

  • Combination Inhalers
  • Inhaled Corticosteroids
  • Long-acting Beta Agonists
  • Leukotriene Modifiers
  • Theophylline

On the basis of region, the asthma treatment market study contains:

  • North America (S., Canada)
  • Latin America (Brazil, Mexico, Argentina, Rest of Latin America)
  • Europe (Germany, Italy, France, U.K., Spain, Benelux, Russia, Rest of Europe)
  • Japan
  • APEJ
  • MEA

Key players analyzed in the asthma treatment market study:

  • Teva Pharmaceutical Industries,
  • AstraZeneca PLC.,
  • Sunovion Pharmaceutical, Inc.,
  • Boehringer Ingelheim, Sanofi,
  • Hoffmann-La Roche Ltd.,
  • Novartis International AG,
  • GlaxoSmithKline PLC,
  • Merck & Co., Inc.

Queries addressed in the asthma treatment market report:

  • How has the global asthma treatment market grown over the historic period of 2020-2027?
  • Why are the asthma treatment market players targeting region for increased product sales?
  • What patented technologies are the players utilizing in the global asthma treatment market?
  • Which regions are displaying the fastest growth in the asthma treatment market?
  • What are the underlying micro- macroeconomic factors affecting the global asthma treatment market?

Access Research Methodology Prepared By Experts –

Why choose Fact.MR?

Reports published by Fact.MR are a result of the combination of our experts and digital technologies. We thrive to provide innovative business solutions to the clients as well as tailor the reports aligning with the clients’ requisites. Our analysts perform comprehensive research to offer ins and outs of the current market situation. Clients across various time zones tend to utilize our 24/7 service availability.

Like it? Share it!


About the Author

Joined: December 18th, 2017
Articles Posted: 13,297

More by this author